Abstract -During surgery, the anaesthetist carefully controls the delivery of anaesthesia given to the patient in an effort to attain and maintain a consistent and adequate level of anaesthetic depth. The aim of this work is to design an internal model control (IMC) for anaesthesia depth, and to test it by simulation with clinical data. This study uses an internal model control structure for the adjustment of Bispectral Index (BIS). Performance of the two controllers has been studied for a step change in BIS, measured disturbances in the measured variables. In this study the simulation shows that the internal model control performed better than the PID controller.
I. INTRODUCTION
During surgery the anaesthetist carefully controls the delivery of anaesthesia given to the patient in an effort to attain and maintain a consistent and adequate level of depth of anaesthesia, that is, adequate levels of hypnotic, analgesic, and paralytic [1] . The anaesthetist is acting as a manual feedback controller [2] . The monitoring and control of unconsciousness in operating theatre is a major challenge to both anaesthetist and machines [3] .
Brain monitors like the BIS monitor can now be use to measure a patient brain response to anaesthesia this information helps clinicians to adjust amount the medication given to improve recovery from anaesthesia, also this information may help clinicians to reduce the risk of patient awareness. In clinical anaesthesia, automatic regulation, in a closed-loop control of infusion of drugs has been shown to provide more benefits when compared to manual administration. A well designed automatic control system can avoid both over-dosage and under-dosage of the drugs. Closed-loop control minimize the drug consumption, intra operative awareness and recovery times, thereby decreasing the cost of the surgery and also the cost of the postoperative care. Overall, this is to improve the patient's safety and rehabilitation during and after the surgery [4] .
The anaesthetist determines any subsequent alteration in the anaesthetic level by observing physical signs from the patient [5] . These physical signs, the indirect indicators of the depth of anaesthesia, may include changes in blood pressures or heart rate, lacrimation (the production of tears in the eyes), facial grimacing, muscular movements, spontaneous breathing, diaphoresis (sweating, especially sweating induced for medical reasons), and other signs that may predicate awareness [6] . However, they are not reliable indicators of 978-1-4244-9324-1/11/$26.00 ©20 11 IEEE 37 changes in patient level of consciousness. Although an anaesthetist can adjust recommended anaesthetic dosages based on individual patient characteristics, these adjustments cannot always account for variability in patient responses to anaesthesia or changes in anaesthetic requirements during the course of surgery [7] .
A major gain of continuous intravenous drug infusion for general anaesthesia is the possibility of keeping something like constant value of the effect concentration of the drug in use [8] . Alson et al. (2008) presents a method for target control infusion for neuromuscular blockade level of patients. The estimates of the pharmacokinetic /pharmacodynamic (PKlPD) model parameters are computed from data collected in the first 10 minutes, after a bolus is applied to the patient in the induction phase of anaesthesia [9] .
Closed loop administration of anaesthetics during surgery promises to supply a number of possible benefits, such as, minimizing the over all amount of drugs required for each person to reduced recovery time and costs, also allowing the anaesthetist to focus on more critical safety tasks [10] . However, in order to design and impalement feedback controls schemes, mathematical model of the patient and drug delivery system are required.
The proposed Internal Model Control (IMC) uses the approximate linear pharmacokinetic-pharmacodynamic (PK PD) model in the controller design, which regulates patient's BIS by manipulating the infusion rate of isoflurane. An extensive simulation conducted to investigation the robustness of the proposed IMC controller, by considering parameters variations in the selected model to account for patient model mismatch. The proposed IMC scheme has also been evaluated for disturbance rejections. The main contributions of this study are to demonstrate the control of hypnosis using IMC, and to compare its performance with traditional PID controller.
The rest of the paper is presented as follows. Section II discusses patient mathematical modeling. The control design is introduced in section 3. Simulations and results are presented in section 4. The main outcome are summarizes in conclusion section.
II. PATIENT MATHEMATICAL MODELS
The human body is assumed to be divided into several compartments to drive the PK model [11] . A model based on a compartmental approach is used. According to this approach, the body is assumed to be divided into several compartments. In each compartment the drug concentration is homogeneous and there are exchanges between compartments. A three compartments model is used, in which the main compartment represents intravascular blood (blood within arteries and veins) and highly irrigated organs (such as heart, brain, liver and kidney). The two other compartments represent muscles, fat and other organs or tissues. The PK consists of a 3-compartment model which is shown in Fig. I , would be represented mathematically by the state equations
where x i is the amount of drug in the i th compartment, k ij is the distribution transfer rate from the i thcompartment to the j thcompartment, k1 0 is the clearance transfer rate out of the central compartment, and I represents the anaesthetic infusion rate into the central compartment [12] . The pharmacodynamics is characterized by a low-pass filter related to the central compartment concentration Cp in blood: (2) where keD and k1e are constants and Xe is the amount of drug in the effect compartment.
(3)
Where Ce denotes the effect site compartemt concentration. Cp denotes plasma concentration. The BIS varaible related to the drug effect concenration Ce by the empirical static non-linear relationship [13] , that is called Sigmoid Hill Curve:
38 where E is the measured effect, Eo represents the baseline value (conscious state without propofol), which is typically set to 100; Emax denotes the maximum effect achieved by the drug infusion; Cso is the drug concentration at half maximal effect and denotes the patient's sensitivity to the drug; and y determines the steepness of the static nonlinearity.
III. THE CONTROL STRUCTURE

A. Internal Model Control
Internal model control relies on the internal model control principle, which states that a plant or a process can be controlled only if the control system incorporates or encapsulates, either implicitly or explicitly, some representation of the process [14] . For example in an open loop control, the model of the process to be controlled is almost exactly known [\5]. However, an exact model of the plant is not known in almost all practical cases and process model mismatch is very common. These uncertainties and un modelled dynamics in the system usually affect system performance. In such cases IMC is found to be very useful [16] . where J?(s) is the space of all real-rational transfer function, r is the input, y is the output and u is the control input [15] . The transfer function from the input r to the error e = r -y is given by B. Internal Model Control fo r Depth of Anaesthesia
The structure of the IMC in depth of anaesthesia (OoA) is depicted in Fig 3. The blocks PK and PO together with the nonlinear equation represent the patient's pharmacokinetics and pharmacodynamics, respectively. Both PK and PO are single-input single-output linear time invariant systems. The equivalent parallel models for the pharmacokinetics and pharmacodynamics are represented by PK and PD respectively together with linearization constant K. The transfer function for the PK in Fig. 3 , can be expressed by:
where C pet) is the drug concentration expressed in microgram per milliliter (propofol), Pl and P2 in the above formula would refer to the rate constant of the distribution phase , and P 3 is the rate constant of the elimination phase.
In many cases, a tri-exponential model will capture significantly better the kinetic of the drug 2 :
A major advantage of exponential models as in (7) is that they can be easily derived using graphical means. The identification can be carried out directly by using either bolus data and analyzing the decaying blood plasma characteristic , or by using infusion data and analyzing how the plasma concentration increases over time.
PD(s) = � + -ys+keo 4ECso
IV. SIMULATION AND RESULTS
(9)
The data from Hospitals are collected into a Matlab spreadsheet program. In case of hardcopy form, the data is entered manually on the Matlab spreadsheet. These data are collected and analysed to establish the relative importance of each independent variable in the prediction. The data analysis results are integrated for model development. The models are developed and designed based on these data analysis and initial results presented. Testing is scheduled to the final stage of model development. In this study, however, the IMC used to generate and provide a much easier framework for design of robust control systems.
The nonlinear DoA model is shown in the block diagram in Fig. 4 . To perform these simulations, Matlab program is developed to compute parameters for both linear and nonlinear Simulink models. The Matlab programs is developed to evaluate the influence of several parameters (Y, keD' and Cp ) on the nonlinear model. At this point, we assume that variability is in both the PK and PD (based on patient's sensitivity to the drug) model parameters. Our control 39 simulations showed that the variability in PD parameters have more impact on BIS than the variability in PK parameters.
This section provides the simulation results of the IMC controller for the control of BIS by manipulating Propofol as shown in Fig. 5 . In Figure 5 , the controller regulates the BIS by adjusting infusion rate of propofol based on the error between set-point and the difference between actual and predicted BIS. The IMC performance is considered in this work and compared with the PID controller the complete close loop system is presented in Fig. 6 . With the PID controller, the settings were Kc -0.088, II = 30.476, and lD = 3.331.
-- The proposed algorithm is simulated using the parameters in Table I , for all 12 patient models. Changes in volumes of the compartments (Vv V2, and V3) has very small effect on the performance. In the PO parameters, higher ECso(3.7) indicates the need for further drug to get the same OoA level, higher Y(3.21) represents higher nonlinearity and lower keo (0.2388) indicates sluggishness in response. For the sensitive patient k i0 , k12' and k13 are low (0.089, 0.084, and 0.031, respectively) and k2v k3v are high (0.0691, and 0.0039, respectively). In the PO parameters, lower ECso(1.6) indicates the need of a smaller amount drug to get the same OoA level, lower Y(2) represents lower nonlinearity, and higher keo(0.4S9) indicates more rapidly response. Also, since keo represents the process gain, higher keo (higher gain) represents faster response and lower keo (lower gain) represents slower response of the process. To come to the point, two parameters (A, n) for IMC, and three parameters (K CJ lI' lD ) for PIO are used for modifying the controller. 10000 12000 
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V. CONCLUSIONS
12000
In this paper, an internal model control, for regulation of anaesthesia using BIS as the controlled variable have been developed and evaluated thoroughly. The performance of this controller is considered along with the performance of the traditional PID controller. In comparison with traditional PID controller, the proposed internal model control is found to be robust to intra-and inter-patient variability, and better at handling disturbances and measurement noise. In system performance, the settling time has been shortened (:::: 4.5 min) and the performance with no undershoot in the IMC, also undershoot was higher with PID controller. The performance of the IMC controller is found to perform the best and hence recommended for DoA control. The proposed IMC strategy was also found to be more robust to intra-and inter-patient variability.
